o d d ¨ ? ¤ nunitedbiopharma.com/msgimages/104年股東常會議事手冊.pdf · Ü ð ô *hsv b...
TRANSCRIPT
6471
( )
16 1
( )
��������
������ ................................................................................................................ 1
����� ................................................................................................................ 2
��� � ............................................................................................................. 3
���� � ............................................................................................................. 4
���� � ............................................................................................................. 5
����
�103������� .......................................................................................... 8
����� !�� ............................................................................................... 11
��"#��$�%&!'�� ........................................................................... 12
(�)*+,- ....................................................................................................... 17
.�/01�234567- ............................................................................... 18
8�9�:;<�=>234567- ............................................................... 20
?�@A� BC234567- ................................................................... 21
D�E ���FG<�=>234567- ................................................... 23
H�I/0E J�KLMN- ........................................................................... 24
O��P
�/01� (23Q) .......................................................................................... 25
��9�:;<�=> (23Q) .......................................................................... 30
��@A� BC (23Q) .............................................................................. 34
(�E ���FG<�=> (23Q) .............................................................. 39
.�RSE ����T@UV ........................................................................... 41
�
1
2
( )
16 1
(1) 103
(2) 103
(3)
(1) 103
(2) 103
(1)
(2)
(3)
(4)
(5)
(6)
(7) 104
3
103
103 ( 8-10 )
103
( 11 )
103 (IFRSs)
IFRSs
4
( )
103
( ) 103
( ) 103
( 8-10 ) ( 12-16 )
( )
103
( ) 103 175,842,938 0
175,842,938
( ) 103 ( 17 )
5
( )
( )
( ) ( 18-19 )
( )
( )
( ) (
20 )
( )
( ) ( 1040001716 )
104 1 27 1030051379
( )
( 21-22 )
6
( )
( ) ( 1040001716 )
103
12 31
( )
( 23 )
( )
( ) 209
( )
( ) ( 24 )
7
( )
( )
10%
( ) 267 10%~15%
( )
( )
( )
( )
104
( ) 103 175,842,938
( ) 104
175,842,938
8
10 94 102
7.1% 103 3,000 103
88 6,371 94 9
2014
17
500 109
5,000
102 9 30
103
103 1
5
7 8
9
11
8,340,000 104 2 7.34
103 11
6.1 ( )
(conceptual design) (basic design) (detailed design)
GE Healthcare FlexFactoryTM
7
103
9
UB-421 9
12
UB-421
UB-421 IIa ( IIa
(HIV-1) UB-421
) 11
UB-421
104 2
UB-421 UB-421
( Drug Holiday )
(HSV) UB-621
103 12 (IND) UB-621
(HSV) WHO 5
2010 HSV 23.5
2010 6.7% HSV
HSV
11 IgE IgE
6 (Lockheed Martin)
(GE Healthcare)
103 9 22 (kickoff
meeting)
104 1 6-8
10
103 104
(2,000 )
11
12
13
14
15
16
17
103
0( ) (175,842,938)( ) (175,842,938)
104 2
18
177
104.6.30
19
102 9 30 102 11 15 102 12 6 103 4 18 103 9 30
102 9 30 102 11 15 102 12 6 103 4 18 103 9 30 104 6 30
20
( )
( )
1.
2.
3.
( )
( )
1.
2.
3.
104.6.30
21
104.6.30
22
23
104.6.30
24
UBI International Group, LLC UBI TW Holdings, LLC UBI CNS Holdings, LLC UBI International IP Holdings, LLC United Neuroscience Limited
( )
( ) ( ) ( )
( )
( ) ( )
( ) ( )
( )
104.6.30
25
26
27
28
29
103 9 30
30
( )
31
32
33
34
35
36
37
38
39
( )
40
( ) ( ) ( ) ( ) ( ) ( )
( )
41
( 104 5 2 )
1,255,911,990 125,591,199
26
8,000,000
800,000
:
76,529,477 60.94%
:
:
:
: 22,999,750 18.31%
:
0 0
0 0
0 0
99,529,227 79.25%
0 0
0 0
800,000 0.64%
800,000 0.64%